Guidance
For Healthcare Providers
- Infection control recommendations for healthcare settings
Until the transmission characteristics of MERS-CoV are better understood, patients under investigation and probable and confirmed cases should be managed according to CDC’s infection control recommendations for the coronavirus that caused SARS. See Appendix A: Type and duration of precautions needed for selected infections and conditions in the 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings
[1.1 MB, 225 pages].
Infection prevention recommendations may be updated as information about transmission and the severity of clinical illness caused by MERS-CoV becomes available.
There is clear evidence of limited human-to-human transmission, possibly involving different modes, such as droplet and contact transmission. But further studies are required to better understand the risks. - Respirator Trusted-Source Information
- Respirator Fact Sheet
For Health Departments
- Interim Guidance for State and Local Health Departments
- Interim Local Health Departments MERS-CoV Investigation Form [1 page] Reviewed Mar 2013
- Interim Local Health Departments MERS-CoV Investigation Form
[1 page] Reviewed Mar 2013
Lab Guidance
- Interim Guidelines for Collection, Processing and Transport of Clinical Specimens from Potential MERS Patients [3 pages] Updated Feb 2013
- Interim Laboratory Biosafety Guidelines for Handling and Processing Specimens Associated with MERS [2 pages] Reviewed Feb 2013
No comments:
Post a Comment